Small-molecule inhibitors of the cancer target, isoprenylcysteine carboxyl methyltransferase, from Hovea parvicalyx

Phytochemistry. 2008 Jun;69(9):1886-9. doi: 10.1016/j.phytochem.2008.04.011. Epub 2008 May 6.

Abstract

Isoprenylcysteine carboxyl methyltransferase (Icmt) is enzyme target in anticancer drug discovery. An Icmt natural product high-throughput screening campaign was conducted and a hit extract from the roots of Hovea parvicalyx was identified. 2'-Methoxy-3'-prenyl-licodione and 2'-methoxy-3',3''-diprenyl-licodione, two prenylated beta-hydroxychalcone compounds, together with the known flavanone (S)-glabrol, were isolated and identified as bioactive constituents. Their structures were determined largely by 1D and 2D NMR spectroscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Enzyme Inhibitors / chemistry*
  • Fabaceae / chemistry*
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Protein Methyltransferases / antagonists & inhibitors*
  • Protein Methyltransferases / metabolism

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Protein Methyltransferases
  • protein-S-isoprenylcysteine O-methyltransferase